2.A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.
Byung Chul YOU ; Young Seok KIM ; Hun Il KIM ; Se Hun KIM ; Seung Sik PARK ; Yu Ri SEO ; Sang Gyune KIM ; Se Whan LEE ; Hong Soo KIM ; Soung Won JEONG ; Jae Young JANG ; Boo Sung KIM
Clinical and Molecular Hepatology 2012;18(3):272-278
BACKGROUND/AIMS: When combined with pegylated interferon alpha-2b (Peg-IFN alpha-2b) for the treatment of genotype 1 chronic hepatitis C (CHC) in Korea, the current guideline for the initial ribavirin (RBV) dose is based on body weight. However, since the mean body weight is lower for Korean patients than for patients in Western countries, current guidelines might result in Korean patients being overdosed with RBV. METHODS: We retrospectively reviewed the medical records of patients with genotype 1 CHC who were treated with Peg-IFN alpha-2b and RBV combination therapy. We divided the patients into groups A (> or =15 mg/kg/day, n=23) and B (<15 mg/kg/day, n=26), given that the standard dose is 15 mg/kg/day. The clinical course in terms of the virologic response, adverse events, and dose modification rate was compared between the two groups after therapy completion. RESULTS: The early response rates (92.0% vs. 83.3%, P=0.634) and sustained virologic response rates (82.6% vs. 73.1%, P=0.506) did not differ significantly between the two groups. During the treatment period, the RBV dose reduction rate was significantly higher in group A than in group B (60.9% vs. 23.1%, P=0.01). CONCLUSIONS: RBV dose reduction is performed frequently when patients are treated according to the current Korean guidelines. Given that lowering the RBV dose did not appear to decrease the virologic response during therapy, reducing RBV doses below the current Korean guideline may be effective for treatment, especially in low-weight patients.
Antiviral Agents/pharmacology/*therapeutic use
;
Body Mass Index
;
Body Weight
;
Dose-Response Relationship, Drug
;
Drug Administration Schedule
;
Drug Therapy, Combination
;
Female
;
Genotype
;
Hepacivirus/drug effects
;
Hepatitis C, Chronic/*drug therapy/virology
;
Humans
;
Interferon-alpha/pharmacology/*therapeutic use
;
Male
;
Polyethylene Glycols/pharmacology/*therapeutic use
;
RNA, Viral/analysis
;
Recombinant Proteins/pharmacology/therapeutic use
;
Retrospective Studies
;
Ribavirin/pharmacology/*therapeutic use
;
Sex Factors
;
Treatment Outcome
3.Establishment of Quality Assessment Standard for Mammographic Equipments: Evaluation of Phantom and Clinical Images.
Sung Hoon LEE ; Yeon Hyeon CHOE ; Soo Young CHUNG ; Mi Hye KIM ; Eun Kyung KIM ; Ki Keun OH ; Hak Hee KIM ; Jeong Mi PARK ; Jeong Hee PARK ; Bo Kyoung SEO ; Hae Kyung LEE ; Eun Ju SON ; Nariya CHO ; Hye Young CHOI ; Byung Jae CHO ; Ji Young KIM ; Eun Suk CHA ; Yong Hwan JEON ; Boo Kyung HAN ; Hyo Keun LIM
Journal of the Korean Radiological Society 2005;53(2):117-127
PURPOSE: The purpose of this study was to establish a quality standard for mammographic equipment in Korea and to eventually improve mammographic quality in clinics and hospitals throughout Korea by educating technicians and clinic personnel. MATERIALS AND METHODS: For the phantom test and on site assessment, we visited 37 sites and examined 43 sets of mammographic equipment. Items that were examined include phantom test, radiation dose measurement, developer assessment, etc. The phantom images were assessed visually and by optical density measurements. For the clinical image assessment, clinical images from 371 sites were examined following the new Korean standard for clinical image evaluation. The items examined include labeling, positioning, contrast, exposure, artifacts, collimation among others. RESULTS: Quality standard of mammographic equipment was satisfied in all equipment during on site visits. Average mean glandular dose was 114.9 mRad. All phantom image test scores were over 10 points (average, 10.8 points). However, optical density measurements were below 1.2 in 9 sets of equipment (20.9%). Clinical image evaluation revealed appropriate image quality in 83.5%, while images from non-radiologist clinics were adequate in 74.6% (91/122), which was the lowest score of any group. Images were satisfactory in 59.0% (219/371) based on evaluation by specialists following the new Korean standard for clinical image evaluation. Satisfactory images had a mean score of 81.7 (1 S.D.=8.9) and unsatisfactory images had a mean score of 61.9 (1 S.D=11). The correlation coefficient between the two observers was 0.93 (p<0.01) in 49 consecutive cases. CONCLUSION: The results of the phantom tests suggest that optical density measurements should be performed as part of a new quality standard for mammographic equipment. The new clinical evaluation criteria that was used in this study can be implemented with some modifications for future mammography quality control by the Korean government.
Artifacts
;
Korea
;
Mammography
;
Quality Control
;
Specialization